Kange Corp. (KGNR) Aktienanalyse
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Kange Corp. (KGNR) ist im Technology-Sektor taetig, zuletzt notiert bei $ mit einer Marktkapitalisierung von 0. Bewertet mit 44/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.
Zuletzt analysiert: 17. März 2026Kange Corp. (KGNR) Technologieprofil & Wettbewerbsposition
Kange Corp. is a technology company specializing in mobile application development, with a focus on creating software for mental health treatments. Operating in the application software industry, Kange Corp. aims to address conditions like autism, dementia, Alzheimer's, and PTSD through its technology-based solutions, setting it apart in a competitive market.
Investmentthese
Kange Corp. presents a speculative investment opportunity within the technology sector, specifically in the application software industry focused on mental health. The company's focus on developing mobile applications for conditions like autism, dementia, Alzheimer's, and PTSD positions it in a niche market with potential for growth. However, with a negative P/E ratio of -1369.43, profitability is a concern. The company's extremely high profit margin of 2157837.5% may be an anomaly or the result of specific accounting practices that require further investigation. Key catalysts include successful development and marketing of new applications, partnerships with healthcare providers, and positive clinical outcomes demonstrating the effectiveness of its technology-based treatments. The negative beta of -0.80 suggests the stock price moves inversely to the market, offering some potential diversification benefits. Investors should carefully assess the company's financial stability, competitive landscape, and ability to execute its business plan before investing.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- Market Cap of $0.20B indicates a small-cap company with potential for growth but also higher risk.
- P/E Ratio of -1369.43 suggests the company is not currently profitable, requiring further investigation into its financial performance.
- Profit Margin of 2157837.5% is exceptionally high and warrants scrutiny to ensure accuracy and sustainability.
- Beta of -0.80 indicates the stock price has historically moved inversely to the market, potentially offering diversification benefits.
- No Dividend Yield reflects that the company is not currently returning profits to shareholders, which is common for growth-oriented companies.
Wettbewerber & Vergleichsunternehmen
Staerken
- Focus on mobile applications for mental health.
- Potential for high profit margins.
- Negative beta suggests potential diversification benefits.
- Addresses a growing market need for mental health solutions.
Schwaechen
- Lack of profitability (negative P/E ratio).
- Small market capitalization increases volatility.
- Limited information available on the company's operations.
- Dependence on successful development and marketing of applications.
Katalysatoren
- Upcoming: Successful development and launch of new mobile applications for mental health.
- Ongoing: Partnerships with healthcare providers to integrate Kange Corp.'s applications into treatment programs.
- Ongoing: Positive clinical outcomes demonstrating the effectiveness of Kange Corp.'s technology-based treatments.
- Upcoming: Expansion into international markets with localized versions of its applications.
- Ongoing: Development and integration of AI-powered features to enhance application functionality.
Risiken
- Potential: Competition from established technology companies and healthcare providers.
- Potential: Regulatory changes in the healthcare industry affecting mobile health applications.
- Potential: Rapid technological advancements rendering Kange Corp.'s applications obsolete.
- Potential: Negative clinical outcomes or user feedback impacting the reputation of its applications.
- Ongoing: Limited financial resources and potential difficulty in securing funding for future growth.
Wachstumschancen
- Expansion into New Mental Health Applications: Kange Corp. has the opportunity to develop and market new mobile applications targeting a broader range of mental health conditions. This could include applications for anxiety, depression, and other common mental health disorders. The global market for mental health applications is projected to reach $17.6 billion by 2027, representing a significant growth opportunity for the company. Timeline: Within the next 2-3 years.
- Partnerships with Healthcare Providers: Kange Corp. can pursue strategic partnerships with healthcare providers, such as hospitals, clinics, and mental health organizations. These partnerships could involve integrating Kange Corp.'s applications into existing treatment programs and offering them to patients as part of their care. This would provide the company with access to a larger customer base and enhance its credibility within the healthcare industry. Timeline: Ongoing.
- International Market Expansion: Kange Corp. can expand its operations into international markets, targeting countries with a growing demand for mental health solutions. This could involve adapting its applications to different languages and cultures, as well as establishing partnerships with local healthcare providers and distributors. The global market for mental health services is expanding, creating opportunities for Kange Corp. to reach new customers and increase its revenue. Timeline: Within the next 3-5 years.
- Development of AI-Powered Features: Kange Corp. can invest in the development of artificial intelligence (AI) powered features for its mobile applications. This could include using AI to personalize treatment plans, provide real-time feedback to users, and predict potential mental health crises. AI-powered mental health solutions are gaining traction, offering the potential to improve the effectiveness and accessibility of mental healthcare. Timeline: Ongoing.
- Integration with Wearable Technology: Kange Corp. can integrate its mobile applications with wearable technology, such as smartwatches and fitness trackers. This would allow the company to collect real-time data on users' physical and mental health, providing valuable insights for personalized treatment plans. The market for wearable technology is growing rapidly, creating opportunities for Kange Corp. to enhance its applications and improve user engagement. Timeline: Within the next 2-3 years.
Chancen
- Expansion into new mental health conditions.
- Partnerships with healthcare providers.
- International market expansion.
- Development of AI-powered features.
Risiken
- Competition from established technology companies.
- Regulatory changes in the healthcare industry.
- Rapid technological advancements.
- Potential for negative clinical outcomes.
Wettbewerbsvorteile
- Specialized Focus: Kange Corp.'s focus on specific mental health conditions creates a niche market position.
- Technology-Based Solutions: The company's emphasis on mobile applications provides a competitive advantage.
- Potential for Innovation: Continuous development of new applications and features can strengthen its moat.
- Partnerships: Collaborations with healthcare providers can enhance market reach and credibility.
Ueber KGNR
Kange Corp., incorporated in 2013 and headquartered in Studio City, California, is a technology company focused on the development and marketing of mobile software products as mobile applications for end-users. The company's primary focus is on providing technology and holistic technology-based health treatments for various mental health conditions. These conditions include autism, dementia, Alzheimer's, and PTSD. Kange Corp. aims to leverage mobile technology to deliver accessible and innovative solutions for individuals and caregivers dealing with these challenging conditions. The company's business model centers around creating and distributing mobile applications that offer therapeutic and supportive tools. These applications are designed to assist in managing symptoms, improving cognitive function, and enhancing the overall quality of life for individuals affected by mental health disorders. Kange Corp. operates within the application software industry, a sector characterized by rapid innovation and evolving user needs. The company's success depends on its ability to develop effective and user-friendly applications that meet the specific requirements of its target audience. Kange Corp. faces competition from other technology companies and healthcare providers in the mental health space. The company differentiates itself by focusing on mobile solutions and integrating technology with holistic treatment approaches.
Was das Unternehmen tut
- Develop mobile software applications for end-users.
- Focus on technology-based health treatments.
- Target mental health conditions such as autism, dementia, and Alzheimer's.
- Offer solutions for PTSD.
- Create applications designed to manage symptoms of mental health conditions.
- Improve cognitive function through mobile technology.
- Enhance the overall quality of life for individuals affected by mental health disorders.
Geschaeftsmodell
- Develop and market mobile applications for mental health treatments.
- Generate revenue through app sales and subscriptions.
- Potentially explore partnerships with healthcare providers for distribution.
- Focus on technology-based solutions for specific mental health conditions.
Branchenkontext
Kange Corp. operates within the application software industry, a dynamic sector driven by technological innovation and evolving consumer needs. The market for mobile health applications is experiencing significant growth, fueled by increasing awareness of mental health issues and the adoption of digital health solutions. Kange Corp.'s focus on technology-based treatments for conditions like autism, dementia, and Alzheimer's positions it within a specialized segment of this market. Competitors include other software developers, healthcare providers, and technology companies offering mental health solutions. The company's success depends on its ability to differentiate itself through innovative applications and effective marketing strategies.
Wichtige Kunden
- Individuals with autism, dementia, Alzheimer's, and PTSD.
- Caregivers of individuals with these conditions.
- Healthcare providers seeking technology-based treatment solutions.
- End-users looking for mobile applications to manage mental health.
Finanzdaten
Chart & Info
Kange Corp. (KGNR) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
Keine aktuellen Nachrichten fuer KGNR verfuegbar.
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer KGNR.
Kursziele
Wall-Street-Kurszielanalyse fuer KGNR.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von KGNR auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Fuehrung: Arthur Malone Jr.
CEO
Arthur Malone Jr. serves as the CEO of Kange Corp. Information regarding his prior experience and educational background is not available. As CEO, he is responsible for overseeing the company's strategic direction, operations, and financial performance. His leadership is crucial to Kange Corp.'s success in the competitive technology and mental health sectors. Further information on his specific qualifications and expertise would provide a more comprehensive assessment of his capabilities.
Erfolgsbilanz: Due to limited information available, it is difficult to assess Arthur Malone Jr.'s track record at Kange Corp. or in previous roles. Key milestones and strategic decisions under his leadership are not readily accessible. A more detailed analysis of his accomplishments and contributions would be necessary to evaluate his effectiveness as CEO.
KGNR OTC-Marktinformationen
The OTC Other tier represents the lowest tier of the OTC market, indicating that Kange Corp. may not meet the minimum financial standards or reporting requirements for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial disclosure and may be subject to greater risks. Investing in OTC Other stocks carries significant risks due to the potential for fraud, lack of liquidity, and limited regulatory oversight. Investors should exercise extreme caution and conduct thorough due diligence before investing in companies on this tier. These companies are not required to be SEC reporting.
- OTC-Stufe: OTC Other
- Offenlegungsstatus: Unknown
- Limited Financial Disclosure: Lack of readily available financial information increases investment risk.
- Low Liquidity: Potential difficulty in buying or selling shares at desired prices.
- Price Volatility: Susceptibility to significant price swings due to limited trading volume.
- Regulatory Scrutiny: Increased risk of regulatory action due to non-compliance with reporting requirements.
- Potential for Fraud: Higher risk of fraudulent activity due to limited oversight.
- Verify the company's registration and legal status.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Understand the risks associated with investing in OTC Other stocks.
- Consult with a financial advisor before investing.
- Check for any regulatory actions or legal proceedings against the company.
- Company's stated focus on developing mobile applications for mental health.
- Headquarters located in Studio City, California.
- Existence of a CEO, Arthur Malone Jr.
- Incorporation date of 2013 suggests some operating history.
- Focus on technology and holistic technology-based health treatments
KGNR Technology Aktien-FAQ
What are the key factors to evaluate for KGNR?
Kange Corp. (KGNR) currently holds an AI score of 44/100, indicating low score. Key strength: Focus on mobile applications for mental health.. Primary risk to monitor: Potential: Competition from established technology companies and healthcare providers.. This is not financial advice.
How frequently does KGNR data refresh on this page?
KGNR prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven KGNR's recent stock price performance?
Recent price movement in Kange Corp. (KGNR) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Focus on mobile applications for mental health.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider KGNR overvalued or undervalued right now?
Determining whether Kange Corp. (KGNR) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying KGNR?
Before investing in Kange Corp. (KGNR), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding KGNR to a portfolio?
Potential reasons to consider Kange Corp. (KGNR) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Focus on mobile applications for mental health.. Additionally: Potential for high profit margins.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of KGNR?
Yes, most major brokerages offer fractional shares of Kange Corp. (KGNR) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track KGNR's earnings and financial reports?
Kange Corp. (KGNR) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for KGNR earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- Limited information available on the company's operations and financial performance.
- OTC Other listing increases investment risk.
- AI analysis pending for KGNR